|
0
|
|
Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and enhanced oxidative damages.
(journals.asm.org)
|
Varik V
…
Van Bambeke F
Antimicrobial Agents and Chemotherapy
2026-01-07
|
#infection
#amr
#virulence
#synergy
#membrane
|
|
0
|
|
Do Akkermansia mutants underlie the global metabolic disease epidemic?
(tandfonline.com)
|
Kim HS
Gut Microbes
2026-01-07
|
#microbiome
#amr
#metabolism
#virulence
#dysbiosis
|
|
0
|
|
Systematic evaluation of computational tools to predict the effects of mutations on protein-ligand binding affinity in the absence of experimental structures.
(academic.oup.com)
|
Pan Q
…
Ascher DB
Briefings in Bioinformatics
2026-01-07
|
#modeling
#amr
#virulence
#mutation
#binding
|
|
0
|
|
Phylogenomics to structure: evolutionary and clinical signals in the TP53 DNA-binding core through LOOCV-validated ensemble learning.
(academic.oup.com)
|
Raza Abbas S
…
Won Lee S
Briefings in Bioinformatics
2026-01-07
|
#modeling
#virulence
#phylogenomics
#mutation
|